Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

Understanding RSV: a significant threat for older adults this flu season ...

Hawaii health officials are preparing for more possible cases as they search for the source of the state's first bird flu ...

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

Recent outbreaks of Legionnaires’ disease have been linked to cruise ship hot tubs, according to CDC reports. Infectious ...

Dr. Beata Halassy, a 49-year-old virologist, self-treated her recurrent breast cancer with OVT, a method that leverages ...

With flu season and the holidays both on the way, it's a good time to get your flu shot. HUNTSVILLE, Ala. — The holiday ...

Experts and health authorities say that while the risk of human infection with the H5N1 strain of avian influenza remains low ...